Macrogen, Inc. (KOSDAQ:038290)
16,330
+430 (2.70%)
Apr 1, 2026, 3:30 PM KST
Macrogen Market Cap
Macrogen has a market cap or net worth of 177.04 billion as of April 1, 2026. Its market cap has increased by 15.80% in one year.
Market Cap
177.04B
Enterprise Value
253.83B
Revenue
179.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
16,330.00
Market Cap Chart
Since September 14, 2000, Macrogen's market cap has increased from 148.29B to 177.04B, an increase of 19.39%. That is a compound annual growth rate of 0.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 172.38B | -5.75% |
| Dec 30, 2025 | 182.89B | 11.21% |
| Dec 30, 2024 | 164.45B | -21.52% |
| Dec 28, 2023 | 209.56B | 8.16% |
| Dec 29, 2022 | 193.74B | -33.59% |
| Dec 30, 2021 | 291.72B | 9.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioneer | 292.43B |
| JETEMA, | 291.29B |
| HLB Therapeutics | 270.64B |
| EASY BIO,Inc. | 235.21B |
| Genexine | 226.94B |
| MedPacto | 195.37B |
| Vaxcell-Bio Therapeutics | 181.64B |
| ENCell | 168.74B |